Those living in rural areas less likely to survive cancer, study shows
December 13, 2018Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban
Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
Government choose England top pharmacist to address overprescribing and polypharmacy
December 13, 2018Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
NICE reject two treatments for fatal, ultra-rare disease – hATTR
December 13, 2018Medical Communications, Research and Development, Sales and Marketing
The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …
The December issue of Pharmafocus is available to read online now!
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma
The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone
December 12, 2018Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
Allergan strengthens Finance Leadership Team with two appointments
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, MIT, Regeneron, appointment, pharma
The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …
Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents
December 12, 2018Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis
UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …
Amgen donate $2m towards increasing diversity in clinical trials
December 12, 2018Research and Development Amgen, USA, clinical trials, diversity, donation
American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access …
Atopic dermatitis market set to almost triple in value over next 10 years
December 12, 2018Research and Development atopic dermatitis, eczema, global data, markets, money
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market …
Tech platform company WuXi Biologics inks deal with cancer specialist Oxford BioTherapeutics worth $450m
December 12, 2018Research and Development Cancer, Oxford Biotherapeutics, WuXi Biologics, alliance, deal, oncology
Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in …
FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics
December 11, 2018Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o
A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …
Woodley Equipment Company Acquires Blinded Diagnostics
December 11, 2018Research and Development POCT, Point of Care Testing, clinical research, clinical trials, point-of-care testing
HORWICH, BOLTON Dec1 2018: Woodley Equipment Company Inc, a leading global supplier of rental equipment for use in Clinical Trials …
Pfizer’s palbociclib most commonly used breast cancer drug in clinical trials
December 11, 2018Manufacturing and Production, Sales and Marketing Cancer, breast cancer, clinical trials, global data, oncology
Pfizer’s palbociclib is the most commonly used breast cancer drug in clinical trials, according to analytics firm GlobalData. The drug, …
Boehringer’s France restructure will cull over 300 jobs
December 11, 2018Manufacturing and Production Boehringer, Sanofi, job cuts, pharma
Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over …
WHO confirm Tanzania FDA as Africa’s first well-functioning regulatory body
December 11, 2018Manufacturing and Production Africa, TFDA, Tanzania, WHO, regulation, regulatory
Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the …
Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’
December 11, 2018Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …
Pfizer announces new UK Managing Director
December 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales
New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …
Psychedelic therapy: A new approach to mental health
December 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy
In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …
AstraZeneca partners up with CRUK for new UK cancer drug discovery facility
December 10, 2018Research and Development, Sales and Marketing AstraZeneca, CRUK, Cancer, pharma
AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery …
Children being treated for problems with Xanax has increased more than 6 times since last year
December 10, 2018Research and Development, Sales and Marketing UK, drug abuse, misuse, prescriptions, valium, xanax
The number of children being treated for problems with benzodiazepine drugs – which include prescription medicines Xanax and Valium – …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
